Osteopenia and Hyperparathyroidism

Summary:

Hyperparathyroidism is found among people with Osteopenia, especially for people who are female, 50-59 old.

The study analyzes which people have Hyperparathyroidism with Osteopenia. It is created by eHealthMe based on reports of 113 people who have Osteopenia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Osteopenia?

Osteopenia (a condition where bone mineral density is lower than normal) is found to be associated with 1,445 drugs and 1,171 conditions by eHealthMe. Check the latest studies of Osteopenia.

What is Hyperparathyroidism?

Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium) is found to be associated with 455 drugs and 445 conditions by eHealthMe. Check the latest studies of Hyperparathyroidism.

On Jul, 15, 2026

113 people who have Osteopenia and Hyperparathyroidism are studied.

Would you have Hyperparathyroidism when you have Osteopenia?

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperparathyroidism?

- Check whether Hyperparathyroidism is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Osteopenia (46,948 reports)
Hyperparathyroidism (5,278 reports)

All the drugs that are associated with Hyperparathyroidism:

Hyperparathyroidism (455 drugs)

All the conditions that are associated with Hyperparathyroidism:

Hyperparathyroidism (445 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperparathyroidism and Osteopenia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Osteopenia and Hyperparathyroidism

Summary:

What is Osteopenia?

What is Hyperparathyroidism?

Gender of people who have Osteopenia and experienced Hyperparathyroidism *:

Age of people who have Osteopenia and experienced Hyperparathyroidism *:

Common co-existing conditions for these people *:

Common drugs taken by these people *:

Common symptoms for these people *: